The Albanese Government expands access to antiviral treatment and offers COVID-19 leave grants to protect older Australians. As we head into the colder months, protecting
The Australian Government has accepted a recommendation from the ATAGI on the use of the Pfizer Comirnaty Bivalent Original/Omicron BA.1 vaccine as a third and
The Albanese government will spend a further $1.4 billion for COVID-19 response, with the majority of the funding going to aged care providers. The money
NSW Health has revised the COVID-19 reinfection period from 12 weeks down to four weeks effective from today. People who have previously had COVID-19 should
NSW Health is urging people to keep up to date with their COVID-19 vaccinations and practise COVID-safe behaviours this winter as COVID-19 transmission in the
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients
Australian COVID-19 cases after the peak of the Omicron wave were at least twice as high as reported to authorities, a blood antibody study shows.
On 25 March 2022, ATAGI recommended an additional winter booster dose (4th dose for most people) for the highest risk groups: the elderly, residents of
Novavax has been approved as a COVID-19 booster for people aged 18 and above. In a statement released on Tuesday, Novavax announced the Therapeutic Goods Administration had
Experts have warned that the 2022 flu resurgence season will redefine what it means for Australia to be ‘flu ready’ as the National Notifiable Disease